Related Experiment Videos
UVB light suppresses nitric oxide production by murine keratinocytes and macrophages
Runa Sur1, Diane E Heck, Thomas M Mariano
1Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08854, USA.
Abstract:
Nitric oxide is an important mediator of excessive cell growth and inflammation associated with many epidermal proliferative disorders. It is a highly reactive oxidant generated in keratinocytes and macrophages via the inducible form of the enzyme nitric oxide synthase (NOS2). In the present studies, we examined the effects of ultraviolet light (UVB, 2.5-25mJ/cm(2)) on interferon-gamma (IFN-gamma)-induced expression of NOS2 in these cells. Transient transfection assays using wild-type and mutant NOS2 promoter/luciferase reporter constructs showed that DNA binding of the transcription factors Stat1 and NF-kappaB was essential for optimal expression of the NOS2 gene. Whereas NF-kappaB was constitutively expressed in both cell types, Stat1 phosphorylation and nuclear binding activity were dependent upon IFN-gamma. UVB light, which is used therapeutically to treat inflammatory dermatosis, was found to suppress IFN-gamma-induced expression of NOS2 mRNA and protein, and nitric oxide production in both keratinocytes and macrophages. In macrophages, this was associated with complete inhibition of NF-kappaB nuclear binding activity and partial (approximately 20-25%) reduction of Stat1 activity. In keratinocytes, both responses were partially reduced at the highest doses of UVB light (15-25mJ/cm(2)). Whereas in macrophages UVB light suppressed NOS2 wild-type promoter-luciferase reporter activity, this activity was stimulated in keratinocytes. These data suggest that UVB light functions to suppress NOS2 gene expression in macrophages by inhibiting the activity of key regulatory transcription factors. In contrast, in keratinocytes, inhibition occurs downstream of NOS2 promoter activity.
Insights
Ultraviolet B (UVB) light suppresses nitric oxide synthase type 2 (NOS2) expression and nitric oxide production in skin cells. This therapeutic effect in inflammatory skin conditions involves differential regulation in macrophages and keratinocytes.
Area of Science:
- Dermatology
- Molecular Biology
- Immunology
Background:
- Nitric oxide (NO) mediates inflammation and cell growth in skin disorders.
- Inducible nitric oxide synthase (NOS2) generates NO in keratinocytes and macrophages.
- Interferon-gamma (IFN-gamma) induces NOS2 expression.
Purpose of the Study:
- To investigate the effect of ultraviolet B (UVB) light on IFN-gamma-induced NOS2 expression.
- To elucidate the molecular mechanisms of UVB action in keratinocytes and macrophages.
Main Methods:
- Transient transfection assays with NOS2 promoter-luciferase constructs.
- Analysis of transcription factor (Stat1, NF-kappaB) activity.
- Measurement of NOS2 mRNA, protein, and NO production.
Main Results:
- UVB suppressed IFN-gamma-induced NOS2 expression, mRNA, protein, and NO production in both cell types.
- In macrophages, UVB inhibited NF-kappaB and partially reduced Stat1 activity, suppressing NOS2 promoter activity.
- In keratinocytes, UVB stimulated NOS2 promoter activity, indicating downstream inhibition.
Conclusions:
- UVB suppresses NOS2 gene expression in macrophages by inhibiting Stat1 and NF-kappaB.
- In keratinocytes, UVB's inhibitory effect on NOS2 occurs downstream of promoter activity.
- UVB's differential regulation of NOS2 in macrophages and keratinocytes has implications for treating inflammatory dermatoses.